Aristeia Capital LLC Aerie Pharmaceuticals Inc Transaction History

Aristeia Capital LLC

  • $2.93 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 18, 2020
SELL
$17.72 - $25.1 $2.68 Million - $3.8 Million
-151,350 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$18.41 - $28.0 $2.79 Million - $4.24 Million
151,350 New
151,350 $2.91 Million

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Aristeia Capital LLC Portfolio

Follow Aristeia Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristeia Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristeia Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email